Andrews William T. 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Nov 24, 2025
Insider Transaction Report
Form 4
Andrews William T.
Chief Medical Officer
Transactions
- Award
Options to purchase common stock
2025-11-20+98,652→ 238,360 totalExercise: $22.77Exp: 2032-11-20→ Common Stock (98,652 underlying) - Award
Restricted Stock Units
2025-11-20+29,776→ 268,136 total→ Common Stock (29,776 underlying)
Footnotes (3)
- [F1]Derivative securities vest in equal tranches, 1/3rd on November 20, 2026, 1/3rd on November 20, 2027 and 1/3rd on November 20, 2028.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F3]Shares of common stock will be delivered to the Reporting Person upon vesting.